beat-sc: phase iii trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage sclc
Published 3 months ago • 61 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
0:40
beat-meso: phase iii trial of bevacizumab and chemo ± atezolizumab for advanced pleural mesothelioma
-
0:54
celebrate: carboplatin, etoposide, bevacizumab and atezolizumab in extensive-stage sclc
-
6:36
atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy ...
-
6:10
ago-ovar 2.29/engot-ov34: atezolizumab vs placebo bevacizumab w/ chemo recurrent ovarian cancer
-
1:49
phase 3 trials of atezolizumab versus standard chemotherapy in pd-l1-selected nsclc
-
1:06
fort 05-beat: comparing 1l atezolizumab vs atezolizumab bevacizumab in pd-l1 high nsclc
-
4:18
impower110: atezolizumab vs chemo in pd-l1–selected nsclc
-
3:21
atezo-chemo benefit in extensive-stage sclc seen outside trials, too - medpage today
-
7:46
results from the phase 2 fast study of astellas’ investigational zolbetuximab
-
4:18
tecentriq branded moa video
-
12:06
jco article insights: atezolizumab plus bevacizumab, chemotherapy in egfr, alk nsclc
-
4:00
atezolizumab plus chemotherapy in extensive-stage small cell lung cancer
-
3:11
impower150: atezolizumab, chemotherapy and bevacizumab for nsclc
-
5:23
atezolizumab carboplatin/etoposide for extensive-stage small cell lung cancer: impower133 update
-
2:35
atezo maintenance therapy improves survival in the impower133 trial of es-sclc
-
0:26
results of celebrate: carboplatin, etoposide, bevacizumab atezolizumab es-sclc
-
4:59
updated survival data from a trial of atezolizumab and chemotherapy for extensive stage small cell l
-
5:05
anti–pd-l1 atezolizumab or chemotherapy as second-line therapy in patients with sclc
-
1:50
impower133: atezolizumab, carboplatin plus etoposide for sclc
-
0:55
the potential of targeted and immune therapies in sclc
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
1:27
fda approval of atezolizumab for nsclc